Announcements
Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for hybrid closed-loop therapy
Dr. Sufyan Hussain
As healthcare professionals, we strive to provide the best possible care for people with type 1 diabetes. One of the most challenging aspects of managing this condition is achieving and maintaining…
Data from the ABCD worldwide EndoBarrier registry published in the current issue of Diabetes Care
Dr. Bob Ryder
Data from the ABCD worldwide EndoBarrier registry published in the current issue of Diabetes Care 1022 patients, 34 centres, 10 countries, shows improvements in weight, glycaemic control and CVD risk…
DTN-UK Committee Recruitment - Experts by Experience Representatives
Professor Pratik Choudhary
The Diabetes Technology Network UK (DTN-UK) are looking for three people with diabetes, who have personal experience of using wearable diabetes technologies (CGM/pump/closed-loop systems) to…
Voting closes soon for the Royal College of Physicians elected councillors
Dr. Dipesh Patel
A reminder to ABCD members that voting closes soon (3 April, midday) for the Royal College of Physicians elected councillors. Two diabetologists are standing for election: Dr David HOPKINS…
Call for information to develop NICE guideline on Adrenal Insufficiency
Dr. Hermione Price
The National Institute for Health and Care Excellence (NICE) have called for evidence for the guideline 'Adrenal insufficiency: acute and long-term management'. They specifically need the following…
Vacancies: Members of the Endocrinology and Diabetes Specialty Certificate Examination Standard Setting Group
Professor Ketan Dhatariya
The Association of British Clinical Diabetologists, the Society for Endocrinology and the Federation of the Royal Colleges of Physicians of the UK are seeking to appoint two new members of the…
Updated guidance on SGLT-2 inhibitors in type 2 diabetes published
Professor Umesh Dashora
ABCD is pleased to announce the updated guidance on SGLT-2 inhibitors in type 2 diabetes. SGLT-2 inhibitors are being used increasingly not only for better diabetes control with less risk of…
